Equitable Vaccine Access Within an Age-Based Framework
Product Description:
Some states prioritize COVID-19 vaccine access by age (decade of life). This is simple, and age has a strong association with COVID-19 mortality. But this raises concerns based in law and ethics.
This study quantifies the age effect: COVID-19 mortality increases 2.59-fold per decade of lifea smaller increase than some conditions.
People with conditions associated with at least 2.59-fold COVID-19 mortality should be granted vaccine eligibility along with people at least 10 years older.
Keyword(s):
equitable vaccine access, covid-19
Product/Publication Type(s):
Reports and monographs
Target Audience:
Consumers/Families, Professionals, Policymakers
Alternative Format:
Electronic (disc, CD, 508 compliant web posting)
To Obtain Copies (URL or Email):
COVID-19 Related Data:
Yes